Target intelligence / Profile preview

AP-3 complex subunit mu-1 (AP3M1)

Target
AP3M1
Molecular classification
Other (Adaptor protein complex)
01

Overview

AP-3 complex subunit mu-1 is the medium (mu) subunit of the adaptor protein complex 3 (AP-3), a heterotetrameric complex composed of two large subunits, a medium subunit, and a small subunit. AP-3 is primarily associated with the Golgi region and peripheral intracellular structures, where it facilitates the formation of vesicles and sorting of proteins, especially into lysosomal and endosomal pathways. The AP-3 complex plays a crucial role in neural vesicle trafficking and cargo selection for synaptic and secretory vesicles, and mutations in AP-3 components have been linked to Hermansky-Pudlak syndrome, a genetic disorder affecting lysosome-related organelles[1][3][5][6]. AP3M1 is not a direct therapeutic target (such as a receptor, enzyme, or transporter) but may be of interest due to its role in vesicle trafficking and disease association; no known drugs directly interact with AP3M1, and it is not used as a biomarker or drug target in current therapeutic contexts[1][5]. It is best classified under "Other" for molecular classification, since it acts as an adaptor protein within an intracellular trafficking complex, rather than as a signaling, receptor, or enzyme protein[1][3][5].

Other names
Adaptor related protein complex 3 subunit mu 1AP-3 adaptor complex mu3A subunitMu-adaptin 3AMu3A-adaptinAP-3 adapter complex mu3A subunitAdapter-related protein complex 3 mu-1 subunitClathrin adaptor complex AP3, mu-3A subunit
02

Biological functions

Intracellular protein sortingVesicle budding from the Golgi membraneTrafficking to endosomes/lysosomesNeural vesicle targeting
03

Disease associations

Neurodegenerative diseaseHermansky-Pudlak syndromeOther

Beyond the preview

Go deeper on AP-3 complex subunit mu-1 (AP3M1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AP-3 complex subunit mu-1 (AP3M1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call